To understand why the "IVF face" is biologically impossible, consider how human faces form. Facial morphology is an intensely polygenic trait. Thousands of independent single-nucleotide polymorphisms interact across the genome to determine the slope of a nasal bridge, the width of a jaw, or the thickness of an eyelid. These alleles pass directly from sperm and egg providers according to classical Mendelian laws and complex polygenic inheritance.
No embryologist chooses an embryo based on facial traits. Standard laboratory grading evaluates structural morphology using metrics like the Gardner scale, developed in the late 1990s. Embryologists grade the expansion of the blastocyst cavity, the cohesiveness of the inner cell mass, and the cellular organization of the trophectoderm. These scores assess whether an embryo has the cellular integrity to implant in the uterine lining and form a placenta. They provide zero visibility into physical appearance.
Similarly, preimplantation genetic testing for aneuploidy (PGT-A) simply counts chromosomes. It verifies that an embryo possesses 46 chromosomes rather than 45 or 47, screening out conditions like Down syndrome (trisomy 21) or Turner syndrome (monosomy X). PGT-M targets specific monogenic hereditary diseases such as cystic fibrosis or Huntington’s disease. Neither tool maps, sequences, or edits cosmetic phenotypes. The technology to "design" facial aesthetics in human embryos does not exist in clinical medicine.
